Liquidia Corporation To Present At The Jefferies Virtual Healthcare Conference
May 26 2021 - 7:00AM
Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Damian
deGoa, Chief Executive Officer of Liquidia, will provide an
overview and update on the company's business during a fireside
chat session at the Jefferies Virtual Healthcare Conference.
The presentation will take place on Wednesday, June 2, 2021,
from 2:30 to 2:55 p.m. Eastern Daylight Time and can be accessed
via a live webcast on the Liquidia website at
https://liquidia.com/investors/events-and-presentations. An
archived, recorded version of the presentation can be accessed for
90 days following the event.
About Liquidia CorporationLiquidia
Corporation is a biopharmaceutical company focused on the
development and commercialization of products in pulmonary
hypertension and other applications of its PRINT® Technology. The
company operates through its two wholly owned subsidiaries,
Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia
Technologies is developing LIQ861, an inhaled dry powder
formulation of treprostinil for the treatment of pulmonary arterial
hypertension (PAH). Liquidia PAH provides the commercialization for
rare disease pharmaceutical products, such as generic Treprostinil
Injection. For more information, please visit www.liquidia.com.
Contact InformationMedia &
Investors:Jason AdairVice President, Corporate Development
and Strategy919.328.4400jason.adair@liquidia.com
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Apr 2023 to Apr 2024